Journal List > Yonsei Med J > v.54(1) > 1031201

TOOLS
Jung, Kim, Hong, Kang, Kim, Chang, Rha, Kim, Kim, and Cho: Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
Retraction
Yonsei Medical Journal

Yonsei Medical Journal 2013; 54(1): 269.

Published online: 28 November 2012

DOI: https://doi.org/10.3349/ymj.2013.54.1.269

Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.

Minkyu Jung1, 2, Se Hyun Kim1, 2, Soojung Hong1, 2, Young Ae Kang3, Se Kyu Kim3, Joon Chang3, Sun Young Rha1, 2, Joo Hang Kim1, 2, Dae Joon Kim4, Byoung Chul Cho1, 2

1Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

2Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

3Division of Pulmonology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

4Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.

© Copyright: Yonsei University College of Medicine 2013

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dear Editor
We deeply regret to inform you that our paper was submitted twice to two different Journals, and was already published in another Journal1; therefore, we are requesting to retract our paper that has been published in YMJ.2 We mistakenly submitted our paper to the other journal. As the corresponding author, I will take full responsibility for this error and respectfully request for the retraction of our paper from YMJ.

References

1. Jung M, Kim SH, Lee YJ, Hong S, Kang YA, Kim SK, et al. Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Exp Ther Med. 2011. 2:685–693.
crossref
2. Jung M, Kim SH, Hong S, Kang YA, Kim SK, Chang J, et al. Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. Yonsei Med J. 2012. 53:931–939.
crossref
TOOLS
Similar articles